Evaluate the ability of ranolazine to favorably modify thrombogenic, inflammatory, lipogenic, oxidative stress and hormonal biomarkers in a relatively short period of time in a group of ethnically diverse women with chronic stable angina and metabolic syndrome.
The purpose of this study is to determine the effects of ranolazine on different markers of cardiometabolic disease in women with stable angina.